SCHEMBL5864909

SCHEMBL5864909

Cc1ccccc1C(O)c1cc2c(=O)n(C)c(=O)n(CC(C)C)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC16A1 P53985 12/20 0.38
PDE1A P54750 4/20 0.38
PDE1B Q01064 4/20 0.38
PDE1C Q14123 4/20 0.38
PDE2A O00408 3/20 0.38
CYP2C9 P11712 2/20 0.38
MAPKAPK2 P49137 1/20 0.38
CAMK2B Q13554 1/20 0.38
HIPK4 Q8NE63 1/20 0.38
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
STAT3 P40763 1/20 0.36
HTT P42858 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864833 0.88 SLC16A1 (0.39) SMN1; SMN2SLC16A1PDE1APDE1BPDE1C
SCHEMBL5864781 0.88 SLC16A1 (0.47) SMN1; SMN2SLC16A1PDE1APDE1BPDE1C
SCHEMBL5865248 0.86 PDE1A (0.41) SMN1; SMN2ALDH1A1SLC16A1PDE1APDE1B
SCHEMBL5864884 0.83 SLC16A1 (0.49) SMN1; SMN2ALDH1A1KMT2ASLC16A1PDE1A
SCHEMBL7007349 0.82 PDE1A (0.38) SMN1; SMN2ALDH1A1SLC16A1PDE1APDE1B
SCHEMBL7006816 0.81 SLC16A1 (0.42) SMN1; SMN2ALDH1A1SLC16A1PDE1APDE1B
SCHEMBL7004534 0.81 PDE1A (0.41) ALDH1A1SLC16A1PDE1APDE1BPDE1C
SCHEMBL8141177 0.80 SLC16A1 (0.39) SMN1; SMN2ALDH1A1SLC16A1PDE1APDE1B
SCHEMBL7006740 0.80 PDE1A (0.38) SMN1; SMN2ALDH1A1KMT2ASLC16A1PDE1A
SCHEMBL5864724 0.79 LMNA (0.42) SMN1; SMN2ALDH1A1KMT2ASLC16A1PDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984644-B2 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones ASTRAZENECA AB (SE) 2006-01-10 US claimed
US-6469014-B1 IMMUNOSUPPRESSIVE ACTIVITY ASTRAZENECA AB (SE) 2002-10-22 US claimed
EP-0991653-B1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2002-10-16 EP claimed
US-6984644-B2 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones ASTRAZENECA AB (SE) 2006-01-10 US disclosed
US-6469014-B1 IMMUNOSUPPRESSIVE ACTIVITY ASTRAZENECA AB (SE) 2002-10-22 US disclosed